bpc 157 cancer cells Everyone’s talking about peptides like this… so let’s actually look at the science., Yes — there is a study on BPC-157 and cancer., But it’s a 2004 conference abstract (not even a full paper), looking BPC 157 Therapy and the

Gastroprotection & Cytoprotection : Consistent with its origin, BPC-157 has repeatedly reduced gastric and intestinal lesion severity in preclinical models and supported mucosal closure.[3] Nitric-Oxide System Balancing : BPC-157 has normalised haemodynamics in settings of both nitric-oxide deficiency and excess, pointing to a homeostatic effect on vascular tone and tissue perfusion

This led to GHK initially being classified as a liver cell growth factor

In a Phase II trial in ulcerative colitis, BPC-157 (also referred to by a code like PL 14736) reportedly helped induce remission of the disease and was noted to be well-tolerated with no side effects

12 weeks (6 vials): 12 mL 2 10 mL bottles 24 weeks (20 vials): 40 mL 4 10 mL bottles 48 weeks (49 vials): 98 mL 10 10 mL bottles Alcohol Swabs One for the vial stopper + one for the injection site each week